COMMUNIQUÉS West-GlobeNewswire

CytomX to Present at the Jefferies 2018 London Healthcare Conference
07/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
Affimed Reports Financial Results for Third Quarter 2018 and Operational Progress
07/11/2018
- Established strategic collaboration agreement with Genentech for NK cell engager-based immunotherapeutics: Received $96 million in upfront and committed funding, may be eligible to receive up to additional $5 billion [...]
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2019 Financial Results on November 12, 2018
07/11/2018
Financials for Second Quarter Fiscal Year 2019 Ended September 30, 2018 will be released November 9, 2018 NORTHVALE, N.J, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: [...]
Homology Medicines Presents Data on Platform’s Ability to Target the Central and Peripheral Nervous System and Therapeutic Potential in the Rare Disease Metachromatic Leukodystrophy
07/11/2018
Homology to Nominate a Clinical Development Candidate for MLD This Quarter and to Begin IND-Enabling Studies in 2019 BEDFORD, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic [...]
Integrated Cannabis Company, Inc. Signs Definitive Agreement with Empower Clinics Inc. and Receives Purchase Order
07/11/2018
VANCOUVER, British Columbia , Nov. 07, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“ Integrated Cannabis ”), is pleased to announce the completion of a Definitive Agreement (“ [...]
Grupo Natac S.L. and Radient Technologies Launch Natac Solutions at SupplySide West
07/11/2018
Advanced-Efficacy Extracts Offer Condition-Specific Functional Benefits EDMONTON, Alberta and MADRID, Spain, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (TSX Venture: RTI) and Grupo Natac S.L. (Natac) [...]
TG Therapeutics, Inc. to Host Conference Call on Third Quarter 2018 Financial Results and Business Update
07/11/2018
Investor Conference Call to be held, Friday, November 9, 2018 at 8:30 AM ET NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Friday, [...]
XOMA Announces Proposed Rights Offering
07/11/2018
Rights Offering will be available to all shareholders of record on November 16, 2018 $20 million to be raised Fully backstopped by BVF Partners L.P. EMERYVILLE, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation [...]
Summit Therapeutics to Participate in Jefferies 2018 London Healthcare Conference
07/11/2018
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Therapeutics to Participate in Jefferies 2018 London Healthcare Conference Oxford, UK, and Cambridge, MA, US, 7 November 2018 – Summit Therapeutics plc (NASDAQ [...]
T2 Biosystems Reports Granting of Inducement Awards
07/11/2018
LEXINGTON, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]
Surgery Partners, Inc. Announces Third Quarter 2018 Results
07/11/2018
Near Term Results Reflect Ongoing Traction of Strategic Growth Initiatives; Continued Investments to Drive Accelerated Growth in 2019 BRENTWOOD, Tenn., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: [...]
ProQR Announces Financial Results for the Third Quarter of 2018
07/11/2018
LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA [...]
Recro Pharma Reports Third Quarter 2018 Financial Results Raising Guidance for CDMO business for 2018
07/11/2018
Company to Host Conference Call Today at 8:00 AM ET MALVERN, Pa., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the [...]
Bellicum Pharmaceuticals to Present at the Jefferies 2018 London Healthcare Conference
07/11/2018
HOUSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2018 Financial Results
07/11/2018
NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
XOMA Reports Third Quarter 2018 Financial Results
07/11/2018
EMERYVILLE, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator, today announced its third quarter 2018 financial results. “The third quarter of 2018 was [...]
CureVac to Present Preliminary Phase I Data on CV8102, an Intratumoral RNA-based Cancer Therapy, at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting
07/11/2018
Data to be presented includes CV8102 as a single agent and in combination with anti-PD1 therapy TÜBINGEN, Germany and BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company [...]
Reata Pharmaceuticals, Inc. Announces Third Quarter 2018 Financial Results and an Update on Development Programs
07/11/2018
IRVING, Texas, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today provided an update on the Company's product development programs and [...]
Protalix BioTherapeutics Reports 2018 Third Quarter Results and Provides Corporate Update
07/11/2018
CARMIEL, Israel, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX, TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]

Pages